Hakon Hov
Overview
Explore the profile of Hakon Hov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Slordahl T, Askeland F, Hanssen M, Hov H, Sundt-Hansen S, Lindahl S, et al.
EJHaem
. 2025 Jan;
6(1):e1091.
PMID: 39866949
Multiple myeloma is characterized by malignant cells which produce high amounts of monoclonal immunoglobulin. Myeloma cells are, therefore, dependent on effective protein degradation. Proteasomal protein degradation is targeted by proteasome...
2.
Hov H, Eithun G, Wang E, Helgerud J
Eur J Sport Sci
. 2024 Jul;
24(7):1010-1020.
PMID: 38956785
Improving peak oxygen uptake (V̇O) and maximal strength are key objectives of rehabilitation for patients with unspecific musculoskeletal disorders (MSDs). Although high-intensity training yield superior outcomes for these factors, patients...
3.
Helgerud J, Hov H, Mehus H, Balto B, Boye A, Finsas L, et al.
Scand J Med Sci Sports
. 2023 Aug;
33(11):2193-2207.
PMID: 37608507
Introduction: Maximal oxygen uptake (V̇O ) is a pivotal factor for aerobic endurance performance. Recently, aerobic high-intensity interval training (HIIT) was documented to be superior to sprint interval training (SIT)...
4.
Hov H, Wang E, Lim Y, Trane G, Hemmingsen M, Hoff J, et al.
Scand J Med Sci Sports
. 2022 Oct;
33(2):146-159.
PMID: 36314990
Maximal oxygen uptake (V̇O ) may be the single most important factor for long-distance running performance. Interval training, enabling high intensity, is forwarded as the format that yields the largest...
5.
Bjerkli I, Laurvik H, Sivy Nginamau E, Soland T, Costea D, Hov H, et al.
PLoS One
. 2020 Sep;
15(9):e0239783.
PMID: 32976535
Background: The majority of oral cavity cancers arise in the oral tongue. The aim of this study was to evaluate the prognostic value of tumor budding in oral tongue squamous...
6.
Fevang B, Fagerli U, Sorte H, Aarset H, Hov H, Langmyr M, et al.
Case Reports Immunol
. 2018 Jun;
2018:2053716.
PMID: 29888014
The nuclease Artemis is essential for the development of T-cell and B-cell receptors and repair of DNA double-strand breaks, and a loss of expression or function will lead to a...
7.
Hjort M, Hov H, Abdollahi P, Vandsemb E, Fagerli U, Lund B, et al.
Exp Hematol Oncol
. 2018 Apr;
7:8.
PMID: 29651360
Background: Phosphatase of regenerating liver-3 (PRL-3) is implicated in oncogenesis of hematological and solid cancers. PRL-3 expression increases metastatic potential, invasiveness and is associated with poor prognosis. With this study,...
8.
Paluchowski L, Nordgaard H, Bjorgan A, Hov H, Berget S, Randeberg L
J Biomed Opt
. 2016 May;
21(10):101413.
PMID: 27228458
Hyperspectral imaging (HSI) is a noncontact and noninvasive optical modality emerging the field of medical research. The goal of this study was to determine the ability of HSI and image...
9.
Tian E, Borset M, Sawyer J, Brede G, Vatsveen T, Hov H, et al.
Genes Chromosomes Cancer
. 2015 Jul;
54(11):692-701.
PMID: 26220195
The growth and survival factor hepatocyte growth factor (HGF) is expressed at high levels in multiple myeloma (MM) cells. We report here that elevated HGF transcription in MM was traced...
10.
Sagberg I, Platou C, Haugnes B, Hov H, Ronne E, Catalan-Serra I
Int J Colorectal Dis
. 2015 Mar;
31(2):473-4.
PMID: 25795174
No abstract available.